产品详情
| 中文名称:4-(2-(4-吗啉苯基氨基)嘧啶-4-基)苯甲酸 | 英文名称:4-(2-(4-MorpholinophenylaMino)pyriMidin-4-yl)benzoic acid |
| CAS:945749-71-3 | 纯度规格: 99%+ HPLC |
| 产品类别: 医药中间体 |
| 级别: 医药级 |
2025-10-24
4-(2-(4-吗啉苯基氨基)嘧啶-4-基)苯甲酸
4-(2-(4-MorpholinophenylaMino)pyriMidin-4-yl)benzoic acid
5KG/RMB;25KG/RMB;100KG/RMB
99%+ HPLC
医药中间体
海步医药原料药&中间体定制能力
01. 研发能力:路线设计、专利挑战、实验室研发、工艺优化、中试放大、工业化转产
02. 生产能力
多个生产场地:GMP原料药工厂、医药中间体工厂
多重生产资质:二类、三类易制毒化学品使用资质、易制爆化学品使用资质、剧毒品使用资质等
多种反应类型:可以承接-20~350°C的常规反应、精馏、氢化、硝化、重氮化、溴化、氨化、氯化等多种反应,可承接从克级到吨级的定制研发生产
03. 质量体系
原料药工厂具备完善的GMP生产质量管理体系和EHS管理体系,通过NMPA、FDA、WHO、EDQM等国际组织认证
医药中间体工厂通过ISO9001认证
关键字: 945749-71-3;莫洛替尼中间体;
公司简介
Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core competence, and has won the title of "China Top 20 Pharmaceutical R&D Company" for several times. Hope Pharma actively builds one-stop service for drug CRO and CDMO, continuously expands its service areas, and establishes good cooperative relations with some leading pharmaceutical companies domestic and abroad.
Hope Pharma has over 20 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc..Our products involve anti-tumor, anti-depressant, anti-epileptic, anxiolytic, cardiovascular and cerebrovascular, digestive system, respiratory system and other indications.
Until now, more than 140 technology transform, over 90 registration approvals and 73 patents has been finished in Hope(including subsidiaries) for past 20 years, and has been rated as a national high-tech enterprise.
| 成立日期 |
2005-04-26
(21年)
|
注册资本 |
4284.6849 万元人民币
|
| 员工人数 |
100-500人 |
年营业额 |
¥ 1亿以上 |
| 主营行业 |
医药中间体,原料药 |
经营模式 |
工厂,定制 |